HZB receives financial support for improving the manufacturing process for CIGS solar cells

Sebastian Schmidt demonstrating one of the CIGS-Modules.

Sebastian Schmidt demonstrating one of the CIGS-Modules. © HZB

The Helmholtz-Zentrum Berlin (HZB) has pulled in a large project for further improving the manufacturing process for CIGS thin-film solar cells together with partners in Germany and from the Netherlands. The atmospheric pressure process operates without involving toxic gases and will be more economical. It will run under the acronym ACCESS-CIGS, which stands for “Atmospheric European Cooperation in Science and Technology (COST) Competitive Elemental Sulpho-Selenisation for CIGS”.

Experts at the Competence Centre Thin-Film- and Nanotechnology for Photovoltaics Berlin (PVcomB) in Adlershof are developing an innovative process to fabricate CIGS layers for application in thin-film solar cells. CIGS stands for the compound Cu(In,Ga)(Se,S)2, consisting of copper, indium, gallium, selenium and sulphur. Polycrystalline CIGS solar cell technology is noted for its high efficiencies at the solar-cell level and high energy yields for solar modules.

The process pursued at PVcomB does not require a vacuum and utilises elementary selenium and sulphur to convert the metallic precursor layer of copper-indium-gallium to a polycrystalline CIGS semiconductor layer. This has the advantage that the process can be carried out without the use of toxic gases such as hydrogen selenide (H2Se), saving on production costs. This might permit the manufacture of CIGS solar modules to be considerably more economical and thus support the currently difficult market situation.

PVcomB has been successful in attracting funding of 800 000 EUR under the SOLAR-ERA.NET Initiative. Staff will be working on the technology as part of a bi-national European consortium over the next two years to optimise the addition of selenium and improve its influence on the crystallisation process.

The project will be carried out in cooperation with the companies TNO/Solliance and Smit Thermal Solutions, both located in Eindhoven, Netherlands, and with the firm Dr. Eberl MBE Komponenten in Weil der Stadt on the German side.

red.

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.